Shares of Medicines (MDCO) shoot up 10.4% premarket after the firm settles patent litigation...

|About: The Medicines Company (MDCO)|By:, SA News Editor

Shares of Medicines (MDCO) shoot up 10.4% premarket after the firm settles patent litigation with Teva Parenteral Medicines in relation to generic versions of Angiomax. As part of the agreement, Teva admits two patents asserted in the lawsuit filed by MDCO are valid and enforceable.